Want to join the conversation?
Andrew Finkelstein of Susquehanna Financial Group asks about commercial execution priorities for 2H16. $AGN said the most important one is RESTASIS. $AGN increased its salesforce by 20% and also its investment in direct-to-consumer advertising. Viberzi and Kybella are the other priorities. The coverage of ophthalmology and optometry will be higher.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.